Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells

14Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

SMAD4 is a tumor suppressor that is frequently inactivated in many types of cancer. The role of abnormal expression of SMAD4 has been reported in developmental processes and the progression of various human cancers. The expression level of SMAD4 has been related to the survival rate in gastric cancer patients. However, the molecular mechanism underlying transcriptional regulation of SMAD4 remains largely unknown. In the present study, we characterized the promoter region of SMAD4 and identifed myeloid zinc fnger 1 (MZF1), as a putative transcription factor. MZF1 directly bound to a core region of the SMAD4 promoter and stimulated transcriptional activity. We also found that the expression of MZF1 influences the migration ability of gastric adenocarcinoma cells. Collectively, our results showed that MZF1 has a role in cellular migration of gastric cancer cells via promoting an increase in intracellular SMAD4 levels. This study might provide new evidence for the molecular basis of the tumor suppressive effect of the MZF1-SMAD4 axis, a new therapeutic target in advanced human gastric cancer.

Cite

CITATION STYLE

APA

Lee, J. H., Kim, S. S., Lee, H. S., Hong, S., Rajasekaran, N., Wang, L. H., … Shin, Y. K. (2017). Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells. International Journal of Oncology, 50(1), 272–282. https://doi.org/10.3892/ijo.2016.3793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free